← Open Payments lookup

KENDRA NESS: Open Payments

NPI 1962892216 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,531 in 83 payments from 16 companies in 2025. Trend: 2023 $1,662 · 2024 $1,347 · 2025 $1,531

Food & beverage: $1,446Education: $85
CompanyPaymentsAmount
ABBVIE INC.23$327
Janssen Biotech, Inc.14$292
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$179
Takeda Pharmaceuticals U.S.A., Inc.7$148
Lilly USA, LLC4$86
Ipsen Biopharmaceuticals, Inc4$74
QOL Medical, LLC3$73
Celltrion USA Inc.3$63
GENZYME CORPORATION3$61
PFIZER INC.4$58

Products named: TREMFYA, RINVOQ, XIFAXAN, MAVYRET, OMVOH, ENTYVIO, IQIRVO, Sucraid.

Industry payments across TX — which companies pay providers there.